• Home
  • Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
16
Jun
2027
National Exhibition and Convention Center
16 Jun 2027 - 18 Jun 2027
stand 82F08
Book a meeting
9
Nov
2027
Messe, Frankfurt
9 - 11 November 2027
stand 80C24
Book a meeting

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

About Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

Nanjing King-Friend Pharmaceutical Co., Ltd. is a pharmaceutical group integrating drug research and development, production and distribution.We're dedicated to providing high-end sterile injectables.
90 ANDAs approved in USA. Top 3 supplier of Heparin and Enoxaparin APIs across the globe. 
Top exporter from China to US of Injetables with over 350 Million USD revenue per year.
All manufacturing sites for Injectables and API manufacturing site accrediated with USFDA,  EMA, PMDA. 

Read more Show less
Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI & PMEC China 2027

    CPHI & PMEC China 2027

    National Exhibition and Convention Center
    16 Jun 2027 - 18 Jun 2027
    stand 82F08
  • CPHI Frankfurt 2027

    CPHI Frankfurt 2027

    Messe, Frankfurt
    9 - 11 November 2027
    stand 80C24
  • Country/Region:
    China
  • Founded:
    1986
  • On CPHI since:
    2022
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Pharmaceutical Company (generic finished products)
Contact info
Show contact info Hide contact info

Products from Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (1)

  • Heparin Sodium/ Enoxaparin Sodium

    Product Heparin Sodium/ Enoxaparin Sodium

    API and FDF both Approved in US, EU, China, Brazil US GMP, EU GMP, Japan GMP, China GMP, Brazil GMP, Mexico GMP available. World’s most stable supply, best quality, competitive price.